Online Pharmacy Health Blog

The study, published in Proceedings of the Royal Society B: Biological Sciences, Britain’s de facto academy of sciences has reported that the low-energy diet that skimps on calories, minerals and nutrients is more likely to yield a female of the human species.

Fiona Mathews, who is with the University of Exeter in Britain and her colleagues wanted to understand why woman’s diet has an impact on the sex of her offspring. They made a research by asking 740 mothers for the first time, that haven’t know if their unborn foetuses were female or male to provide detailed records of eating habits before and after they became pregnant. It was made three groups of women sorted by the number calories they consumed per day around the time of conception.

Thanks to this experiment 56 % of the women in the group with the highest energy intake had sons, other 45 % for the least-well fed cohort.The group who produced more males were also more likely to have eaten a wider range of nutrients, including potassium, calcium and vitamins C, E and B12, beside racking up a higher calorie count.

According to the results of two brand new studies, - the new Roche anti-arthritis drug, which has been tasted, is effective in relieving the symptoms of rheumatoid arthritis in children as well as in adults.

It works by blocking the interleukin-6 receptor, which is a molecule involved in promoting the painful inflammation in rheumatoid arthritis.

As it was done in these studies, tocilizumab isn’t so placebo, convinced especially for adults. This is a expert opinion, but it better drug than existing medications.

The U.S. Food and Drug Administration has approved Nexium (esomeprazole magnesium), which is used to treat gastroesophageal reflux disease (GERD) in children ages 1-11 years. It was approved by the agancy in two specific forms: a liquid form and delayed-release capsule. The Nexium medication will go in the following dosage: in 20 mg or 40 mg recommended for pediatric patients 12 to 17 years of age old compared to 10 milligrams (mg) or 20 mg daily for children 1-11 years old.

Nexium is part of a class of drugs known as proton pump inhibitors (PPIs). PPIs decrease the amount of acid produced in the stomach and help heal erosions in the lining of the esophagus known as erosive esophagitis.

“This approval provides important information for appropriate dosing for children ages 1-11 years with GERD,” said Julie Beitz, M.D., director of the FDA’s Office of Drug Evaluation III in the Center for Drug Evaluation and Research. “Children prescribed this drug should be monitored by their physicians for any adverse drug reactions.”

Myobloc taking place, Botox Cosmetic and Ongoing safety review of Botox

Myobloc (Botulinum toxin Type B) and Botox and Botox Cosmetic (Botulinum toxin Type A) have been related in some cases to adverse reactions such as: following treatment of a variety of conditions using a wide range of doses, respiratory failure and death. This was notified publicly by the U.S. Food and Drug Administration today.
The reactions might be connected to overdosing, according to the early communication based on the FDA’s ongoing safety review. No evidence was found, that these reactions have something to do with the defects in the products.
They have been found in FDA-approved and non approved usages. Found in Children treated for spasticity in their limbs associated with cerebral palsy are the most severe adverse effects. The treatment of spasticity is not an FDA-approved use of botulism toxins in adults or children.
These adverse reactions appear to be related to the spread of the toxin to areas distant from the site of injection also and the mimic symptoms of botulism, that might have breathing problems, swallowing and weakness.
Prescribing these products by the health care professionals can continue, advising the FDA.

Official Announcement 

FDA with the association of manufacturers will the working on including this new information in the labeling for these products and that way they will appear on the market,” says the US drug safety regulator.

On Friday, the US drug safety regulator informed that the anti-epileptic drugs used to cure migraine headaches, epilepsy and other conditions carry a risk of suicidal behavior and thoughts.